RSK4 confers paclitaxel resistance to ovarian cancer cells, which is resensitized by its inhibitor BI-D1870

紫杉醇 卵巢癌 抗药性 癌症研究 化疗 癌细胞 医学 内科学 生物 癌症 肿瘤科 药理学 微生物学
作者
Yoko Nagumo,Myra O. Villareal,Hiroko Isoda,Takeo Usui
出处
期刊:Biochemical and Biophysical Research Communications [Elsevier BV]
卷期号:679: 23-30 被引量:5
标识
DOI:10.1016/j.bbrc.2023.08.060
摘要

Many ovarian cancers initially respond well to chemotherapy, but often become drug-resistant after several years. Therefore, analysis of drug resistance mechanisms and overcoming resistance are urgently needed. Paclitaxel is one of the first-choice and widely-used drugs for ovarian cancer, but like most drugs, drug resistance is observed in subsequent use. RSK4 is known as a tumor-suppressor, however, it has increasingly been reported to lead to drug resistance. Here, we found that RSK4 expression was elevated in paclitaxel-resistant ovarian cancer cells using DNA microarray, quantitative real-time PCR, and western blotting analysis. We examined the contribution of RSK4 to paclitaxel resistance and found that paclitaxel sensitivity was restored by RSK inhibitor co-treatment. We analyzed the mechanism by which resistance is developed when RSK4 level is elevated, and accelerated phosphorylation of the downstream translation factor eIF4B was discovered. In the Kaplan-Meier plot, the overall survival time was longer with RSK4 high, supporting its role as a tumor suppressor, as in previous findings, but the tendency was reversed when focusing on paclitaxel treatment. In addition, RSK4 levels were higher in non-responders than in responders in the ROC plotter. Finally, external expression of RSK4 in ovarian cancer cells increased the cell viability under paclitaxel treatment. These findings suggest that RSK4 may contribute to paclitaxel resistance, and that co-treatment with RSK4 inhibitors is effective treatment of paclitaxel-resistant ovarian cancer in which RSK4 is elevated.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
亮亮完成签到,获得积分10
刚刚
CipherSage的应助被开心德地采纳,获得10
刚刚
1秒前
1秒前
1秒前
叶子完成签到,获得积分10
2秒前
要减肥明雪完成签到,获得积分10
2秒前
森森芊芊完成签到,获得积分10
4秒前
Nole的应助被大气十三采纳,获得10
4秒前
乔乔发布了新的文献求助10
6秒前
好吃懒做发布了新的文献求助10
7秒前
英俊的铭的应助被开心德地采纳,获得50
8秒前
gsx发布了新的文献求助10
8秒前
一蓑烟雨任平生完成签到,获得积分10
10秒前
zz完成签到 ,获得积分10
10秒前
lin_jiayi完成签到,获得积分10
10秒前
超级无敌的应助被齐嘉懿采纳,获得10
10秒前
陈辉完成签到,获得积分10
11秒前
11秒前
11秒前
11秒前
12秒前
醉熏的碧凡完成签到,获得积分10
13秒前
JamesPei的应助被章鱼采纳,获得10
13秒前
十一完成签到 ,获得积分10
14秒前
科研通AI65的应助被王知颖采纳,获得10
14秒前
zik发布了新的文献求助10
15秒前
sjnc发布了新的文献求助10
16秒前
李健的应助被开心德地采纳,获得10
17秒前
小马甲的应助被猪猪hero采纳,获得10
17秒前
苗条的听莲完成签到,获得积分10
17秒前
19秒前
zkylh的应助被ttchen采纳,获得10
20秒前
Nole的应助被pipi采纳,获得10
20秒前
好吃懒做完成签到,获得积分10
21秒前
gsx完成签到,获得积分10
22秒前
23秒前
23秒前
乔乔完成签到 ,获得积分20
23秒前
闪闪的幻儿完成签到,获得积分10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188451
求助须知:如何正确求助?哪些是违规求助? 9576286
关于积分的说明 21846376
捐赠科研通 7786514
什么是DOI,文献DOI怎么找? 3435343
关于科研通互助平台的介绍 2559618
邀请新用户注册赠送积分活动 2482322